http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104644573-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
filingDate 2015-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2017-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104644573-B
titleOfInvention Carry arsenic trioxide pH response mesoporous silicon dioxide nano particles and preparation method thereof
abstract The preparation method that arsenic trioxide pH responds mesoporous silicon dioxide nano particle is carried the invention discloses a kind of, mainly preparing amino modified mesoporous silicon oxide, Electrostatic Absorption including coprecipitation is loaded into the step of ATO, PAA acid-base conjugate prepare PAA ATO MSNs.Outward appearance is rounded under PAA ATO MSNs transmission electron microscopes prepared by the present invention or similar round, and average grain diameter is(158.6±1.32)Nm, Zeta Current potential is(‑28.40±0.34)MV, envelop rate and drugloading rate are respectively(40.95±3.21)%,(11.42±1.75)%.Tablets in vitro has pH responses, and cumulative release amount reduces and increased with pH.Pharmacokinetic studies show, compared with ATO Sol and ATO MSNs, PAA ATO MSNs t 1/2β Significantly extension, AUC is significantly increased(P<0.01).PAA ATO MSNs tablets in vitro has obvious pH responses and slow release characteristic, can be obviously improved rat Internal pharmacokinetics behavior, and the carrier has preferable application prospect as ATO cancer target delivery systems.
priorityDate 2015-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011099932-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415783356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409060395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID977
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID518740
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5974
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14798
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID44681
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4432
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87486
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450766143
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID44681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID545
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25244225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423390483
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID423217529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482173
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523291
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53627726

Total number of triples: 46.